HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peri-implantitis increases the risk of medication-related osteonecrosis of the jaws associated with osseointegrated implants in rats treated with zoledronate.

Abstract
This study evaluated the peri-implant tissues under normal conditions and under the influence of experimental peri-implantitis (EPI) in osseointegrated implants installed in the maxillae of rats treated with oncologic dosage of zoledronate. Twenty-eight senescent female rats underwent the extraction of the upper incisor and placement of a titanium dental implant (DI). After eight weeks was installated a transmucosal healing screw on DI. After nine weeks, the following groups were formed: VEH, ZOL, VEH-EPI and ZOL-EPI. From the 9th until the 19th, VEH and VEH-EPI groups received vehicle and ZOL and ZOL-EPI groups received zoledronate. At the 14th week, a cotton ligature was installed around the DI in VEH-EPI and ZOL-EPI groups to induce the EPI. At the 19th week, euthanasia was performed, and the maxillae were processed so that at the implanted sites were analyzed: histological aspects and the percentage of total bone tissue (PTBT) and non-vital bone tissue (PNVBT), along with TNFα, IL-1β, VEGF, OCN and TRAP immunolabeling. ZOL group presented mild persistent peri-implant inflammation, higher PNVBT and TNFα and IL-1β immunolabeling, but lower for VEGF, OCN and TRAP in comparison with VEH group. ZOL-EPI group exhibited exuberant peri-implant inflammation, higher PNVBT and TNFα and IL-1β immunolabeling when compared with ZOL and VEH-EPI groups. Zoledronate disrupted peri-implant environment, causing mild persistent inflammation and increasing the quantity of non-vital bone tissue. Besides, associated with the EPI there were an exacerbated inflammation and even greater increase in the quantity of non-vital bone around the DI, which makes this condition a risk factor for medication-related osteonecrosis of the jaws.
AuthorsEduardo Quintão Manhanini Souza, Luan Felipe Toro, Vinícius Franzão Ganzaroli, Jéssica de Oliveira Alvarenga Freire, Mariza Akemi Matsumoto, Cláudio Aparecido Casatti, Luciano Tavares Ângelo Cintra, Rogério Leone Buchaim, João Paulo Mardegan Issa, Valdir Gouveia Garcia, Leticia Helena Theodoro, Edilson Ervolino
JournalScientific reports (Sci Rep) Vol. 14 Issue 1 Pg. 627 (01 05 2024) ISSN: 2045-2322 [Electronic] England
PMID38182598 (Publication Type: Journal Article)
Copyright© 2024. The Author(s).
Chemical References
  • Zoledronic Acid
  • Tumor Necrosis Factor-alpha
  • Vascular Endothelial Growth Factor A
  • Interleukin-1beta
Topics
  • Female
  • Animals
  • Rats
  • Bone-Anchored Prosthesis
  • Peri-Implantitis (etiology)
  • Zoledronic Acid (adverse effects)
  • Tumor Necrosis Factor-alpha
  • Vascular Endothelial Growth Factor A
  • Inflammation
  • Interleukin-1beta
  • Osteonecrosis
  • Jaw

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: